PharmaShots

JANUARY 27, 2023

Magenta Therapeutics Pauses the P-I/II Study in AML Patients Date: Jan 27, 2023 | Tags: Magenta Therapeutics, MGTA-117, AML, Clinical Trial, P-I/II Ipsen Receives CHMP Negative Opinion for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva Date: Jan 27, 2023 | Tags: Ipsen, Palovarotene, Fibrodysplasia Ossificans Progressiva, Regulatory, CHMP, (..)

FDA 40

FDA Immunization 40

European Pharmaceutical Review

MAY 22, 2023

Benefits of blockchain technology in the pharma supply chain Blockchain technology can address these issues in the pharmaceutical supply chain by providing timely data and increase shared data’s authenticity, integrity , and invariability. This can reduce the willingness for counterfeit and less accurate data, according to the review.

93

93

Pharmaceutical Technology

JUNE 29, 2022

AI is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 3.1% in May 2022.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies 110

Pharmaceutical Technology

JULY 25, 2022

Machine learning is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 1.2% in June 2022.

Pharmaceutical Companies 93

Pharmaceutical Companies Pharmaceutical Companies 93

Pharmaceutical Technology

JULY 6, 2022

The proportion of pharmaceutical companies hiring for big data related positions rose in June 2022 compared with the equivalent month last year, with 68.4% of companies who were hiring for big data related jobs a year ago and the same as the figure of 68.4% This latest figure was higher than the 65.7% in May 2022. in June 2022.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies 64

European Pharmaceutical Review

DECEMBER 9, 2022

According to the report data, in 2021, antisense oligos accounted for the largest share of this segment, since many of these therapies are currently in clinical trials. The data indicated primers are anticipated to show the highest growth in the synthesised oligos market over the forecast period. Tag Copenhagen A/S (Denmark).

Compounding 89

Compounding 89

Pharmaceutical Technology

NOVEMBER 9, 2022

Artificial intelligence is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 2.9% in October 2022.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies 69

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Communication 52

Communication 52

Pharmaceutical Technology

NOVEMBER 7, 2022

Artificial intelligence is one of the topics that GlobalData, our parent company and from whom the data for this article is taken, have identified as being a key disruptive technology force facing companies in the coming years. less time on average compared to similar jobs across the entire jobs market.

84

84

Pharmaceutical Technology

AUGUST 1, 2022

The proportion of pharmaceutical companies hiring for data analytics related positions dropped in July 2022 compared with the equivalent month last year, with 64.8% of companies who were hiring for data analytics related jobs a year ago and a decrease compared to the figure of 69.7% This latest figure was lower than the 68.8%

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 18, 2022

The proportion of pharmaceutical companies hiring for data analytics related positions rose in June 2022 compared with the equivalent month last year, with 70.1% This latest figure was higher than the 65% of companies who were hiring for data analytics related jobs a year ago and an increase compared to the figure of 67.8% in May 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 3, 2022

Amylyx Pharmaceuticals’ Relyvrio – a new treatment for amyotrophic lateral sclerosis (ALS) approved by the FDA on Thursday, after review of the data from its phase 2 trial – was the next day set at a list price of $158,000 per year in the US, sparking outcry. ALS affects over 30,000 people in the US.

Insurance 52

Insurance FDA 52

Roots Analysis

JANUARY 28, 2024

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. Within the healthcare sector, structured data includes demographic details, vital indicators (like, height, weight, blood pressure, blood glucose).

Health and Personal Care Stores 40

Health and Personal Care Stores Medical Records Hospitals 40

Pharmaceutical Technology

JUNE 27, 2022

Cybersecurity is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 2.8% in May 2022.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

JULY 27, 2022

Robotics is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.6% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 13, 2022

Digitalization is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 11% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 4, 2022

Cloud is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 6.3% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 8, 2022

Internet of things is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.9% in October 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 23, 2022

Robotics is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.6% in May 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 8, 2022

Digitalization is one of the topics that GlobalData, our parent company and from whom the data for this article is taken, have identified as being a key disruptive technology force facing companies in the coming years. more time on average compared to similar jobs across the entire jobs market.

59

59

Roots Analysis

MARCH 1, 2024

Examples of such technologies include DNA Taggants (a unique DNA tag used in the product / packaging that can be scanned using a designated instrument / equipment), invisible printing technologies, digital watermark technologies and hidden markers / print technologies.

Packaging 52

Packaging Labelling 52

Pharmaceutical Technology

SEPTEMBER 21, 2022

Industrial automation is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 5.6% in August 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 10, 2022

Industrial automation is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 5.8% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 8, 2022

Future of work is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 3.3% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 3, 2022

Internet of things is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.9% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 20, 2022

Internet of things is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 0.9% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 11, 2022

Digital media is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. The average among all companies stood at 4.7% in June 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Virtual connections. Is there legacy branding? How can we help consolidate all of that material?

Communication 91

Communication Insurance Packaging Pharmaceutical Companies 91

pharmaphorum

JANUARY 24, 2022

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. For its part, IBM has said that the Watson for Oncology product has been improving year-on-year as the AI crunches more and more data.

Cerner 110

Cerner 110

pharmaphorum

JULY 23, 2019

Focus New developments in data and digital are changing traditional customer journeys and forcing pharmaceutical companies to evolve in order to keep up. The expert panel will consider exclusive research carried out by Tag and pharmaphorum across the US, Europe and Asia-Pacific among senior decision-makers in pharma and FMCG marketing.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 9, 2022

On November 7, the company announced that the FDA has scheduled a pre-licensure inspection of BioMarin’s manufacturing facility, and required the company to submit three-year Phase III Roctavian data in the approval application. million price tag. The post Can gene therapies for haemophilia defend their high price tags?

FDA 111

FDA 111

Pharmaceutical Technology

DECEMBER 15, 2022

This extrapolation leverages data from GlobalData’s World Markets Healthcare and PharmOnline International databases to expand the number of markets in GlobalData’s patient-based sales forecast model from seven major markets (7MM) to 68 markets (68M). The second highest contributing market is APAC, generating 33.2%

52

52

Pharmaceutical Technology

MAY 1, 2023

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. Additionally, both the companies will share CTH-004 pre-clinical and clinical data in future.

52

52

DiversifyRx

JUNE 23, 2023

It offers segmentation, tagging, and scheduling capabilities. And most importantly, you can automate funnels and gather vital data on your email subscribers. It can double as a sales CRM which means you can view your sales and marketing data in one place, which is really handy when comparing your efforts. A few reasons why.

52

52

pharmaphorum

NOVEMBER 19, 2021

There are still uncertainties about Evrysdi, according to NICE, but it will be provided via the NHS on an interim basis while more data is collected. million price tag make it is the most expensive treatment ever approved for NHS funding.

98

98

pharmaphorum

NOVEMBER 16, 2021

“We look forward to the full technology appraisal guidance (TAG) which is due to be published in early December 2021,” he added. An opinion from the Scottish Medicine Consortium (SMC) on the use of the drug by NHS Scotland is expected to be published early in 2022.

Documentation 96

Documentation 96

pharmaphorum

MARCH 23, 2022

Vyvgart (efgartigimod alfa) became the first drug in the FcRn class to be approved by the FDA last December, and despite a $225,000 annual price tag is predicted to make relatively modest sales in its IV version, which will compete with other IV gMG drugs like AstraZeneca/Alexion’s C5 inhibitor Soliris (eculizumab).

FDA 52

FDA 52